Publications by authors named "Marc Bogard"
Article Synopsis
- New technologies for reading human genes started in the early 2000s, leading to companies offering genetic tests directly to customers without needing a doctor’s order.
- In the United States, many of these companies faced restrictions between 2009 and 2013, while they are completely banned in France.
- There are still concerns about the safety and usefulness of these genetic services, and many experts believe we need better rules to manage them internationally as they become more popular.
[Genomic medicine: the new way of thinking medicine present and future--Part two].
Ann Biol Clin (Paris)
October 2014
Article Synopsis
- New machines are making it easier to study our genes, changing how doctors help patients.
- Analyzing genes can lead to better treatments, especially for cancers and other illnesses.
- This publication explains how these new gene techniques are changing medical practices and the challenges that come with them.
Before initiating new large-scale therapeutic trials for hepatitis C virus (HCV)-infected patients, the French Health Authorities for HCV research decided to organize an evaluation of the expertise of laboratories that could be engaged to undertake molecular biology assays in such trials; 21 experienced laboratories participated in this national evaluation of laboratory expertise, which was performed in two successive rounds. The first round evaluated the laboratories for their abilities to detect HCV RNA in serum, determine genotypes, and quantify HCV RNA loads. The results observed by qualitative assays for HCV RNA detection were 100% sensitivity and 100% specificity for all laboratories.
View Article and Find Full Text PDF